The global antibody market is poised for remarkable expansion over the next decade, with market estimates predicting a significant rise in valuation from USD 266.83 billion in 2024 to an impressive ...

Monoclonal antibodies are essential for biomedical research and cancer treatments due to their targeted action. These laboratory-made molecules act like the natural antibodies in our immune system ...

“Automation has already been heavily utilized in many aspects of mAb manufacturing, such as process control, monitoring, and testing. Continued investment in automation will further reduce cost by ...

Monoclonal antibodies (mAbs) are medications that target specific proteins to help reduce inflammation in people with severe asthma. The FDA has approved six mAbs for asthma treatment so far.

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

Despite the hundreds of millions of vials of blood drawn every year for medical testing, scientists have only scratched the surface of its diagnostic potential. The blood proteome — which ...

Long-lasting in vivo antibody production: DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepoint No anti-drug antibodies (ADA): no immune rejection of ...

This eBook explores how innovative medium and feed systems can support the successful scale-up of mAb processes, while ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

A shuttered Milanese manufacturing site with a storied history is getting a new lease on life, thanks to a nearly ...